Pharma Television
December 1, 2007
Fintan Walton talks to John Clerici, a partner in McKenna Long & Aldridge, whose practice is in Public Health Preparedness. This interview covers the funding available from the US Government to commercial companies for the development of technologies to protect public health (such as the prevention of flu pandemics and other viral outbreaks) and bioterrorism. Since 9/11, the US Government has increased its spending on these areas and will partner with companies (US or non-US) to accelerate the development of relevant products. John Clerici also covers what commercial organisations should be aware of in entering into these partnerships, and what they should be aiming for. Executed correctly, partnerships with the US Government can result in a product that benefits both public health and the fight against bioterrorism, and the pharmaceutical or biotech company concerned.
To watch this interview, please click here.